lyxumia solution for injection in pre-filled pen 10mcg and 20mcg (50mcgml and 100mcgml)
sanofi-aventis singapore pte. ltd. - (10mcg) lixisenatide; (20mcg) lixisenatide - injection, solution - 0.05mg/ml - (10mcg) lixisenatide 0.05mg/ml; (20mcg) lixisenatide 0.1mg/ml
lyxumia solution for injection in pre-filled pen 20mcg (100mcgml)
sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 100mcg/ml - lixisenatide 100mcg/ml
zaltrap concentrate for solution for infusion 25 mgml
sanofi-aventis singapore pte. ltd. - aflibercept - infusion, solution concentrate - 25.0 mg/ml - aflibercept 25.0 mg/ml
toujeo solostar solution for injection
sanofi-aventis deutschland gmbh - insulin glargine - solution for injection - 300iu/ml
apidra
sanofi-aventis deutschland gmbh - insulin glulisine - diabetes mellitus - drugs used in diabetes - treatment of adults, adolescents and children, six years or older with diabetes mellitus, where treatment with insulin is required.
insuman
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insuman rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.
suprefact depot 3-months
sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).
insulin lispro sanofi
sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.
eloxatin 50mg vial concentrate for solution for infusion
sanofi aventis deutschland gmbh, germany - oxaliplatin - concentrate for solution for infusion - 50 mg
eloxatin 100mg vial concentrate for solution for infusion
sanofi aventis deutschland gmbh, germany - oxaliplatin - concentrate for solution for infusion - 100 mg